AAPLSApellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc

APLS

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive APLS chart

  • Mkt cap

    $2.29B

  • EV/Sales

    1.82

  • P/E ratio

    N/A

  • FY2025 Revenue

    $1.00B

  • EPS (9mo ended 2025-09-30)

    $0.65

  • Gross Margin (FY2025)

    N/A

  • Profit Margin (FY2025)

    2.23%

  • Beta

    0.67

  • Div yield

    N/A

  • Sector

    Healthcare

Live APLS terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

APLS — Apellis Pharmaceuticals Inc · rev $1.00B

APLS Key Statistics

  • Market Cap: $2.29B

Apellis Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full APLS income, balance, and cash tables.

  • Revenue$1.00B
  • Net Income$22.4M
  • Total Assets$1.08B
  • Free Cash Flow$45.0M

APLS recent filings

APLS FAQ

What industry is APLS in?

Apellis Pharmaceuticals Inc (APLS) is a biotechnology company in the Healthcare sector.

What are APLS's latest revenue and net income?

Latest cached Apellis Pharmaceuticals Inc (APLS) revenue for Dec 31, 2025 was $1.00B. Net income was $22.4M. Statements: https://lician.com/financials/apls

What is APLS's market cap?

Apellis Pharmaceuticals Inc (APLS) market capitalization is $2.29B on the latest cached snapshot.

When was APLS's latest earnings event?

Apellis Pharmaceuticals Inc (APLS) latest cached earnings event is "APLS earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings

What is the latest APLS SEC filing?

The latest cached APLS filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/apls

Live APLS terminal loads when you scroll near this section.